✦ LIBER ✦

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

✍ Scribed by Edward Gane; Faouzi Saliba; Garcia JC Valdecasas; John O'Grady; Mark D Pescovitz; Susan Lyman; Charles A Robinson

Book ID: 117310759
Publisher: The Lancet
Year: 1997
Tongue: English
Weight: 76 KB
Volume: 350
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(97)05535-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Valganciclovir vs

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

✍ Carlos Paya; Atul Humar; Ed Dominguez; Kenneth Washburn; Emily Blumberg; Barbara 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Efficacy and safety of low-dose valganci

Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients

✍ Jeong M. Park; Kathleen D. Lake; Juan D. Arenas; Robert J. Fontana 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

The efficacy and safety of valganciclovir (VGCV) for cytomegalovirus (CMV) prophylaxis in liver transplant recipients has not been established. We retrospectively compared the efficacy and safety of low-dose oral VGCV (450 mg once daily for 90 days) and standard oral ganciclovir (1 g three times a d

Prevention of primary cytomegalovirus di

Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis

✍ R.H. Rubin; S.A. Kemmerly; D. Conti; M. Doran; B.M. Murray; J.F. Neylan; C. Papp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Prevention of cytomegalovirus disease in

Prevention of cytomegalovirus disease in transplant recipients

✍ DrewJ Winston 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 341 KB

Prevention of cytomegalovirus disease in

Prevention of cytomegalovirus disease in transplant recipients

✍ DavidR. Snydman; MatthewE. Falagas 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 355 KB

Preemptive Therapy With Intravenous Ganc

Preemptive Therapy With Intravenous Ganciclovir for the Prevention of Cytomegalovirus Disease in Lung Transplant Recipients

✍ V. Monforte; A. Román; J. Gavaldà; C. Bravo; P. Gispert; A. Pahissa; F. Morell 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB